Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InspireMD (NSPR) Gross Margin (2016 - 2025)

Historic Gross Margin for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to 34.24%.

  • InspireMD's Gross Margin rose 113700.0% to 34.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 24.91%, marking a year-over-year increase of 23100.0%. This contributed to the annual value of 21.49% for FY2024, which is 76400.0% down from last year.
  • InspireMD's Gross Margin amounted to 34.24% in Q3 2025, which was up 113700.0% from 17.6% recorded in Q2 2025.
  • Over the past 5 years, InspireMD's Gross Margin peaked at 34.24% during Q3 2025, and registered a low of 8.59% during Q3 2021.
  • In the last 5 years, InspireMD's Gross Margin had a median value of 22.87% in 2024 and averaged 22.21%.
  • Data for InspireMD's Gross Margin shows a peak YoY increase of 2681400bps (in 2021) and a maximum YoY decrease of -218200bps (in 2021) over the last 5 years.
  • InspireMD's Gross Margin (Quarter) stood at 21.3% in 2021, then fell by -9bps to 19.3% in 2022, then surged by 49bps to 28.68% in 2023, then fell by -16bps to 24.06% in 2024, then surged by 42bps to 34.24% in 2025.
  • Its Gross Margin stands at 34.24% for Q3 2025, versus 17.6% for Q2 2025 and 19.1% for Q1 2025.